| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | DAIICHI SANKYO, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$130,000 | |
| 2025 | DAIICHI SANKYO, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$90,000 | |
| 2025 | DAIICHI SANKYO, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$220,000 | |
| 2025 | DAIICHI SANKYO, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$260,000 | |
| 2025 | DAIICHI SANKYO, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$210,000 | |
| 2024 | DAIICHI SANKYO, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$600,000 | |
| 2024 | DAIICHI SANKYO, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$220,000 | |
| 2024 | DAIICHI SANKYO, INC. |
2nd Quarter (Apr 1 - June 30) AMENDED |
$250,000 | |
| 2024 | DAIICHI SANKYO, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$240,000 | |
| 2024 | DAIICHI SANKYO, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$170,000 |
| Firm | Filings | Expenses |
|---|---|---|
| DAIICHI SANKYO, INC. | 63 | $6,730,000 |
| Issue | Activities |
|---|---|
| Health Issues | 49 |
| Medicare/Medicaid | 37 |
| Copyright/Patent/Trademark | 20 |
| Trade (domestic/foreign) | 8 |
| Taxation/Internal Revenue Code | 8 |
| Pharmacy | 7 |
| Budget/Appropriations | 5 |
| Consumer Issues/Safety/Products | 2 |
| Manufacturing | 1 |
| Advertising | 1 |
| Insurance | 1 |
| Torts | 1 |